✦ LIBER ✦

P-473 Phase II trial of temozolomide and innotecan as second-linetreatment for advance non-small cell lung cancer

✍ Scribed by Choong, N.; Mauer, A.; Hoffman, P.; Ma, P.; Cohen, E.; Rudin, C.; Kozloff, M.; Sciortino, D.; Szeto, L.; Vokes, E.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P-573 Docetaxel-innotecan doublet chemot

✍ Shamseddine, A.; Abou-Mourad, Y.; Makarem, J.; Kattan, J.; Farhat, F.; Jalloul, 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 182 KB

P-3 A phase II trial of the combination

✍ Winegarden, Jerome D.; Rudin, Charles M.; Mauer, Ann M.; Hoffman, Philip; Szeto, 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 338 KB

Phase II trial of gemcitabine as second

✍ Gillenwater, HH; Tynan, M; Socinski, MA 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 129 KB

A phase II trial testing gemcitabine as

✍ Sculier, J.P; Lafitte, J.J; Berghmans, T; Thiriaux, J; Lecomte, J; Efremidis, A; 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 77 KB

Phase II trial of taxotere and cisplatin

✍ Ho, J; Lam, W; Ip, M; Nguyer, T; Tsang, K.W.T 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 103 KB

Phase II trial of mitoxantrone and cispl

📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 135 KB